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Collision-induced dissociation (CID) was performed on multiply deprotonated ions from three
commercial peptides: hirudin (54–65), fibrinopeptide B, and oxidized insulin chain A. Ions
were produced by electrospray ionization in a Fourier transform ion cyclotron resonance mass
spectrometer. Each of these peptides contains multiple acidic residues, which makes them very
difficult to ionize in the positive mode. However, the peptides deprotonate readily making
negative ion studies a viable alternative. The CID spectra indicated that the likely deprotona-
tion sites are acidic residues (aspartic, glutamic, and cysteic acids) and the C-terminus. The
spectra are rife with c, y, and internal ions, although some a, b, x, and z ions form. Many of the
fragment ions were formed from cleavage adjacent to acidic residues, both N- and C-terminal
to the acidic site. In addition, neutral loss (e.g., NH3, CH3, H2O, and CO2) was prevalent from
both the parent ions and from fragment ions. These neutral eliminations were often indicative
of specific amino acid residues. The fragmentation patterns from several charge states of the
parent ions, when combined, provide significant primary sequence information. These results
suggest that negative mode CID of multiply deprotonated ions provides useful structural
information and can be worthwhile for highly acidic peptides that do not form positive ions
in abundance. (J Am Soc Mass Spectrom 2000, 12, 105–116) © 2000 American Society for
Mass Spectrometry
Since its genesis in the 1980s, electrospray ioniza-tion (ESI) [1, 2] has developed into a routinetechnique for the analysis of a wide variety of
organic, bio-organic, and inorganic compounds. The
majority of these studies have involved positive ions
that are generated by proton addition to basic sites.
However, many biologically significant proteins and
peptides contain several acidic residues (e.g., glutamic
and aspartic acids) or post-translational modifications
to produce acidic groups (e.g., phosphates or sulfon-
ates). Such peptides can be difficult to analyze by mass
spectrometry in the positive ion mode [3, 4]. For these
compounds, the negative ion mode, which relies on
sites of deprotonation, may yield a stronger ion signal.
Over the past decade, the dissociation of protonated
protein and peptide ions has been the subject of hun-
dreds of investigations that have yielded sequence and
conformational information [5–10]. In contrast, rela-
tively little work has focused on the fragmentation of
negatively charged peptide ions. In studies on tri- and
tetrapeptides ionized by fast atom bombardment (FAB),
it was reported that small peptide negative ions pro-
duce fewer fragments than positive ions. However, the
two modes of dissociation often yield complementary
structural information [11–16]. Recent investigations in
our laboratory [17–19] employing matrix-assisted laser
desorption ionization (MALDI) post-source decay
(PSD) [20–22] time-of-flight (TOF) mass spectrometry
have shown that positive and negative ion PSD provide
complementary information on peptide primary struc-
tures. In fact, for several peptides containing acidic
residues, more sequence information was obtained in
the negative ion mode than in the positive mode [17].
Bowie [13–16, 23–25], Beauchamp [26], and their
co-workers have investigated the collision-induced dis-
sociation (CID) of small singly charged deprotonated
peptides. They found that cleavage at acidic residues is
prevalent [23]. In addition, loss of small neutrals such as
CO2, NH3, H2O, and CH3 from fragments is common.
Only a handful of studies have dealt with the dissocia-
tion of multiply charged negative peptide and protein
ions. Loo et al. [4] reported the facile generation of such
ions using solutions with ammonium hydroxide added
to yield a pH of ;11. In the same study, CID results
were presented for [M 2 3H]32 and [M 2 4H]42 of
oxidized insulin chain A, as studied in a triple quadru-
pole mass spectrometer. The spectra revealed several
doubly and triply charged b and y ions including
significant loss of SO3 (80 Da). Loss of SO3 was also
reported by Gibson and co-workers [27, 28]. Summer-
field and Gaskell [29] studied the decomposition of
[M 2 2H]22 for three small peptides containing cysteic
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acid. They found that sequestration of the charge on this
highly acidic residue was detrimental to dissociation.
In the present study, we use three commercial pep-
tides to explore the viability of obtaining sequence
information from low-energy CID on multiply charged
negative ions. The multiply deprotonated ions, [M 2
nH]n2, of hirudin (54–65) (n 5 2 and 3), insulin chain
A (oxidized) (n 5 4 and 5), and fibrinopeptide B (n 5
3 and 4) were studied in a Fourier transform ion
cyclotron resonance (FT-ICR) mass spectrometer. Un-
fortunately, attempts to generate multiply charged pos-
itive ions for all three highly acidic peptides were futile.
Figure 1 shows the one letter amino acid sequence
codes for the three peptides with potential deprotona-
tion sites given in boldface. Each of these peptides
contain multiple acidic residues; thus, it is not surpris-
ing that they produce very little or no multiply charged
ions in the positive mode, but generate abundant mul-
tiply charged negative ions.
Experimental
All experiments were performed using a Bruker (Bil-
lerica, MA) BioApex 47e FT-ICR mass spectrometer
with a 4.7 tesla superconducting magnet [30]. Details on
the instrument configuration have been previously re-
ported [31]. Ions were generated by an Analytica of
Branford (Branford, CT) electrospray source employing
pneumatic-assist ESI [32, 33].
For CID experiments with sustained off-resonance
irradiation (SORI) [34], ions were activated 500–1200
Hz off resonance (either higher or lower frequency)
with a pulsed voltage of 6.0–18.9 Vp-p for times of
100–150 ms. The collision gas was xenon, which
reached a maximum pressure of 1025 torr. For experi-
ments with on-resonance CID [35], ions were activated
with voltages ranging from 195 to 300 Vp-p for times of
up to 15 ms.
All peptides were purchased from Sigma Chemical
(St. Louis, MO) and were used without further purifi-
cation. Solutions ranging in concentration from (1.6 to
2.7) 3 1025 M were formed in 50:50:1 mixture of meth-
anol : water : ammonium hydroxide that had a pH of
9–11. The solution was introduced into the electrospray
source at a flow rate of 5–10 mL/min and was sprayed
across a 13 kV potential through a 225 °C N2 counter-
current drying gas at .60 lb/in.2. The pneumatic-assist
gas was N2 at 20 lb/in.
2.
Results and Discussion
Negative Ion CID Nomenclature
Figure 2 is a schematic of the nomenclature employed
in the present work to describe the negative ion frag-
ments. It is based on the positive ion nomenclature of
Roepstorff and Fohlman [36]. The a, b, and c ions
incorporate the N-terminus, while the x, y, and z series
contain the C-terminus. The subscript n corresponds to
the number of the amino acid residue (from the N-
terminus) and R denotes the corresponding side chain.
The charge on the fragment is denoted by j2. The
number of hydrogens lost is also indicated in the
structures. The high resolution capability of the FT-ICR
facilitates determination of the number of hydrogens
lost for multiply charged ions. However, because of the
complexity of the spectra presented here, more research
on smaller synthetic peptides is required to clearly
assign sites of deprotonation and to ascertain mecha-
nisms.
Our FT-ICR data from multiply charged ions indi-
cate that a-, c-, y-, and z-ion series have a hydrogen
differential of 2(j 2 1), or 2j 1 1, relative to the
hypothetically neutral cleaved fragment. Thus, singly
charged members of these series (j 5 1) have no added
Figure 1. Amino acid sequences for fibrinopeptide B, hirudin
(54–65), and insulin chain A oxidized. Potential deprotonation
sites are in boldface. Figure 2. Nomenclature and structure of dissociation fragments
for multiply charged negative peptide ions.
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or lost hydrogens. In making these assignments, the
experimentally observed assignments agreed within
60.02 m/z units of the theoretical value. For instance,
fibrinopeptide B gives a theoretical a2
12 ion of 141.066
m/z; this ion was found at 141.065 m/z in the FT-ICR
spectra. These assignments of 2(j 2 1) differential hy-
drogens agree with PSD results from our laboratory
[17–19].
Assignments of hydrogen differential for the x and b
ions were less unambiguous than the other ion series. In
a few instances, multiply charged x ions displayed a
loss of j hydrogens (2j), whereas in other cases there
was a 2(j 2 1) hydrogen differential. In this initial
study, we observed very few b ions and their appear-
ance in conjunction with neutral loss complicated the
spectra. As a result, a definitive determination on the
number of hydrogens lost or gained for b ions could not
be made in this study. The b-ion assignments reported
here used a 2(j 2 1) hydrogen differential, which was
also our assignment in prior PSD studies [17–19]. How-
ever, recent work in our laboratory on simpler peptide
systems suggests that b ions often have a 2(j 1 1)
hydrogen differential [37]. This differential, which
would mean that b ions in the negative mode have two
fewer hydrogens than their positive counterparts, has
also been reported by Kulik and Heerma [11] for singly
deprotonated ions. Efforts to resolve these issues as of
assignment for multiply deprotonated b and x ions are
currently underway in our laboratory. However, be-
cause neither ion is seen in abundance in the present
work, this ambiguity does not affect the present results.
Hirudin (54–65) [M 2 3H]32 and [M 2 2H]22
Hirudin (54–65) is a fragment of the 65 residue protein,
hirudin, which is the most prolific anticoagulant
known. This highly anionic region of the protein is
believed to be the active site for binding to thrombin,
which hinders blood clotting [38]. Assuming that neg-
ative ions are typically deprotonated at the carboxylic
acid group at the C-terminus and the side chains of
aspartic acid (D) and glutamic acid (E) residues, hirudin
Figure 3. SORI-CID mass spectra of (a) [M 2 2H]22 and (b)
[M 2 3H]32 for hirudin (54–65).
Table 1. Table of standard cleavages and neutral loss for [M 2 2H]22 for hirudin (54–65)
Hir (54–65) G Da F E E I P E E Y L Q
n 5 1 2 3 4 5 6 7 8 9 10 11 12
bn w
12b
y(132n) w
12 w12
[an 2 45] w
12
[bn 2 36] w
12
[bn 2 61] w
12
[cn 2 35] w
12 m12
[x(132n) 2 33] w
12
[x(132n) 2 17] w
12
[x(132n) 2 36] w
12
[y(132n) 2 18] w
12 m12 w12
[y(132n) 2 34] w
12
[y(132n) 2 36] w
12 s,c [M 2 18]22
[z(132n) 2 36] w
12 m, [M 2 36]22
w, [M 2 54]22
aPotential deprotonation sites in boldface.
bIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
cNeutral loss from parent ion.
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(54–65) has six possible deprotonation sites. Our spec-
tra show a maximum charge state of 32, with 22 and
12 also being observed. This lack of full deprotonation
might result from the close proximity of the glutamic
acid residues (E4 E5 or E8 E9), which increases coulom-
bic repulsion and thus may allow only one site of
deprotonation between two adjacent residues.
For these initial studies, we investigated the dissoci-
ation of [M 2 nH]n2, n 5 3 and 2. Their SORI-CID
spectra are shown in Figure 3. Tables 1–4 provide a
detailed listing of the observed fragments for these two
ions from SORI-CID mass spectra. Tables 1 and 3 list the
standard cleavages, their relative intensities, and perti-
nent neutral losses for [M 2 2H]22 and [M 2 3H]32,
respectively. Tables 2 and 4 list the internal fragment
ions, their relative intensities, and neutral losses.
The spectra of the two parent ions are quite different,
with more fragments being observed for [M 2 3H]32.
This mirrors the increased dissociation efficiency that is
found as the charge increases for positive ions [39–42].
More highly charged ions have increased coulombic
repulsion that enhances dissociation.
Table 2. Table of internal ion fragments and neutral loss for [M 2 2H]22 of hirudin (54–65)
Hir (54–65)
n 5
G
1
Da
2
F
3
E
4
E
5
I
6
P
7
E
8
E
9
Y
10
L
11
Q
12
Internal ionc
w12,b(b1y9)2 2 61 w
12, (b8y2)2 2 18
w12, (b4y5)3 2 57
w12, (b4y6)2 2 18 w
12, (b7y3)2 2 36
w12, (b4y6)2 w
12, (b8y2)2 2 36
w12, (b7y3)2 2 18
m12, (b2y7)3 2 18
w12, (b1y5)6 2 44
w12, (b3y5)4
s12, (b5y2)5 2 36
aPotential deprotonation sites in boldface.
bIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
cThe internal ion is composed of the underlined residues.
Table 3. Table of standard cleavages and neutral loss for [M 2 3H]32 for hirudin (54–65)
Hir (54–65)
n 5
G
1
Da
2
F
3
E
4
E
5
I
6
P
7
E
8
E
9
Y
10
L
11
Q
12
an w
22
bn w
12 w12
cn w
12 b
y(132n) w
22 w12
[bn 2 17] w
12
[bn 2 36] w
12
[bn 2 61] w
12
[cn 2 17] w
12
[cn 2 18] w
22
[cn 2 34] w
12 w12
[cn 2 35] w
12 w12 w12 w22, w12
[cn 2 36] w
12 w22
[cn 2 52] w
12 w12
[x(132n) 2 17] w
12
[x(132n) 2 35] w
12
[y(132n) 2 17] w
12
[y(132n) 2 18] w
22 w12 m22, w12 w12
[y(132n) 2 34] w
12
[y(132n) 2 36] w
32, w22 w12 w12
[y(132n) 2 44] w
12
[y(132n) 2 53] w
32 s,c [M 2 18]32
[y(132n) 2 54] w
22 m, [M 2 36]32
w, [M 2 54]32
aPotential deprotonation sites are in boldface.
bIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
cNeutral loss from parent ion.
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The data of Figure 3 reveal a predominance of c, x,
and y series and internal ion fragments, which involve
two cleavages of the peptide backbone. Very few a, b,
and z series fragments are formed. The spectra show
significant neutral loss; in particular, H2O (18 Da) and
NH3 (17 Da). Sequential loss of H2O occurs (e.g., [y8 2
36]12) and the loss of combinations of neutrals is very
common (e.g., [x6 2 35]
12, where H2O 1 NH3 5 35
Da, and [b3 2 61]
12, where CO2 1 NH3 5 61 Da). As
Tables 1 and 3 indicate, the parent ions for both charge
states eliminate multiples of H2O; for example, [M 2
18]n2, [M 2 36]n2, and [M 2 54]n2 (where n 5 2 and
3). Loss of H2O is indicative of glutamic acid or aspartic
acid residues. Loss of NH3 is associated with asparagine
(N) residues [16, 43] and the present results suggest also
with glutamine (Q). Other neutral eliminated include
CO2 (44 Da) and CH3 (15 Da). Also, in Table 4, the
internal ion [(b4y5)3 2 57]
12 is consistent with the pres-
ence of isoleucine (I6). In singly deprotonated peptide
ion CID, Bowie and co-workers have found that both
isoleucine and leucine lose their butyl side chains (57
Da) [13–16, 23–25, 44]. In general, neutral loss is indic-
ative of a specific amino acid residue and, in this
manner, provides sequence information.
The fragments listed in Tables 1–4 suggest that the
acidic residues (D, E, and the C-terminus) are likely
sites of deprotonation [4, 45] and that these residues
promote backbone fragmentation and side chain cleav-
ages [23, 25]. Most fragments include at least one acidic
residue and cleavage is often (but not always) adjacent
to an acidic residue; for instance y2
12 and y8
12 in Table 1
or c2
12 and y6
22 in Table 3. The doubly charged y6
22 ion,
is most likely deprotonated at one of the glutamic
residues (E8, E9) and the C-terminus. Cleavage can
occur both N- and C-terminal to the site of deprotona-
tion. For example, b3
2 involves cleavage N-terminal to
E4 and includes D2. The internal ions frequently involve
cleavages adjacent to acidic residues; for example,
(b3y4)4
12, [(b7y3)2 2 2H2O]
12 (Table 2) and [(b8y2)2 2
H2O]
12 and (b9y1)2
12 (Table 4). The y ions, which
incorporate the C-terminus, are dominated by loss of
H2O (18 Da). The c ions, which incorporate the N-
terminus, lose a combination of H2O and NH3 (35 Da);
for instance, fragments involving c2, c3, c5, and c7. These
results are consistent with PSD data [46, 47], where
Figure 4. SORI-CID mass spectra of (a) [M 2 3H]32 and (b)
[M 2 4H]42 for fibrinopeptide B.
Table 4. Table of internal ion fragments and neutral loss for [M 2 3H]32 of hirudin (54–65)
Hir (54–65)
n 5
G
1
Da
2
F
3
E
4
E
5
I
6
P
7
E
8
E
9
Y
10
L
11
Q
12
Internal ionb
w12,c (b1y9)2 2 61 w
12, (b4y6)2 2 17 w
12, (b8y2)2 2 18
w12, (b4y5)3 2 57
m12, (b4y6)2 2 18 w
12, (b8y2)2
w12, (b4y6)2 w
2, (b9y1)2
m12, (b4y5)3
w12, (b4y5)3 2 54
m12, (b2y7)3 2 18 w
12, (b7y1)4
w12, (b3y5)4
aPotential deprotonation sites are in boldface.
bThe internal ion is composed of the underlined residues.
cIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
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Table 5. Table of standard cleavages and neutral loss for [M 2 3H]32 of fibrinopeptide B
Fib. B
n 5
pEa
1
G
2
V
3
N
4
Db
5
N
6
E
7
E
8
G
9
F
10
F
11
S
12
A
13
R
14
an w
12c w12
cn m
12 w12 s12 w12
y(152n) w
12 w12 w12
[an 2 35] w
12
[an 2 18] w
12 w12
[an 2 17] w
12
[bn 2 34] w
22
[bn 2 36] w
12 w22
[bn 2 35] w
12
[cn 2 34] w
12
[cn 2 35] w
12 w12
[cn 2 18] w
12 m12 w12
[cn 2 17] m
12 w12
[x(152n) 2 36] w
12
[x(152n) 2 18] w
12
[y(152n) 2 54] w
22
[y(152n) 2 36] w
22 w22 w12
[y(152n) 2 17] w
22, w12
[y(152n) 2 18] w
12
[y(152n) 2 42] w
12
[z(152n) 2 33] w
12 w,d [M 2 34]32
w, [M 2 44]32
apE symbolizes pyroglutamic acid.
bPotential deprotonation sites in boldface.
cIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
dNeutral loss from parent ion.
Table 6. Table of internal ion fragments and neutral loss for [M 2 3H]32 of fibrinopeptide B
Fib. B
n 5
pEa
1
G
2
V
3
N
4
Db
5
N
6
E
7
E
8
G
9
F
10
F
11
S
12
A
13
R
14
Internal ionc
w12,d (b3y10)1 s
12, (b7y6)1
m21, (b1y11)22 w
12, (b4y8)1 2 35
w12, (b7y5)2
w12, (b3y9)2 2 17 w
12, (b8y4)22
w12, (b6y6)2
w12, (b4y8)2 2 18
w12, (b4y8)2 2 17 w
12, (b9y3)2
w12, (b1y10)3 2 17 w
12, (b6y5)3 2 18
w12, NDN 2 34 w12, (b8y3)3
w12, (b6y5)3
w22, (b6y2)6
w22, (b6y1)7 2 30
m22, (b5y2)7 2 44
w12, (b2y7)5 2 34 w
12, (b9y1)4 2 35
w12, (b8y2)4 2 17
w12, (b9y1)4 2 18
w12, (b7y3)4
w22, (b3y2)9 2 18
w12, (b4y5)5 2 34
w12, (b7y2)5 2 36
w12, (b7y1)6
apE symbolizes pyroglutamic acid.
bPotential deprotonation sites in boldface.
cThe internal ion is composed of the underlined residues.
dIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
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N-terminal fragments such as b and c ions were re-
ported to lose NH3 and, in some instances, H2O. Fur-
thermore, the loss of H2O is observed from the aspartic
acid and glutamic acid residues in the fragments (D2,
E4, and E5).
Using on-resonance CID, breakdown curves (not
shown) were made of relative abundance for represen-
tative fragments versus laboratory frame collision en-
ergy, Elab. The more highly charged [M 2 3H]
32 has
greater coulomb energy than [M 2 2H]22 and thus
achieves significant dissociation at a lower threshold
value of Elab (;20 eV vs. 30 eV). For both parent ions,
loss of H2O is the lowest energy pathway. This is
consistent with the fact that rearrangements to elimi-
nate stable neutrals are lower energy processes than
direct cleavages. At slightly higher energies cleavage of
the peptide backbone occurs, while internal ions dom-
inate at even higher energies. This is expected because
internal ions involve cleavages at two bonds in the
peptide backbone. In addition, loss of H2O and other
neutrals from the fragments becomes more prominent
at higher collision energies. One particularly interesting
process is the loss of CO2 from y2
12; this high energy
fragment is observed for [M 2 3H]32, but not [M 2
2H]22. Loss of CO2 has been reported to originate from
the C-terminal residue in dissociations of di- and tri-
peptide [M 2 H]2 [13–15, 48].
Differences in fragmentation between the two charge
states contribute to primary structure elucidation. For
instance, the largest y ion observed for hirudin [M 2
2H]22 is [y9 2 H2O]
12. The higher charge state pro-
duces [y11 2 36]
n2 (n 5 2 and 3) as its largest y frag-
ment. In addition, the internal ions can provide se-
quence information because the residues in the
fragments overlap; for example, (b7y1)4
12, (b9y1)2
12, and
[(b8y2)2 2 H2O]
12. The fragmentation patterns for the
two charge states are therefore complementary to each
other and provide a wealth of primary sequence infor-
mation. In addition, SORI-CID produced fragments that
were not observed by on-resonance CID; thus, SORI-
CID yielded a greater amount of structural information.
This is consistent with positive ion studies, where
McLafferty and co-workers [41] found that SORI-CID
provided more efficient dissociation than on-resonance
CID for multiply charged positive ions.
Fibrinopeptide B [M 2 4H]42 and [M 2 3H]32
Fibrinopeptide B is a 14 residue peptide that is impor-
tant in blood clotting. This peptide, along with fibrino-
peptide A, is cleaved by thrombin from fibrinogen to
initiate the formation of the blood clot. These anionic
peptides are known to hinder fibrinogen aggregation by
charge–charge repulsion [38]. Potential deprotonation
sites in fibrinopeptide B are its three acidic residues and
the C-terminus. Consistent with this, our spectra
showed a maximum negative charge state of 42.
Figure 4 gives the SORI-CID mass spectra for [M 2
3H]32 and [M 2 4H]42. Tables 5 and 7 list the standard
cleavage fragments and neutral loss for [M 2 3H]32
and [M 2 4H]42, respectively. Tables 6 and 8 show the
internal ions and their neutral eliminations. Similar to
Table 7. Table of standard cleavages and neutral loss for [M 2 4H]42 for fibrinopeptide B
Fib. B
n 5
pEa
1
G
2
V
3
N
4
Db
5
N
6
E
7
E
8
G
9
F
10
F
11
S
12
A
13
R
14
an w
12c
cn w
12 w12 m12 w22
x(152n) w
42
y(152n) w
32 w12 w12
[an 2 34] w
12
[an 2 35] w
12 m,d[M 2 62]42
[an 2 18] w
12 w12 m,[M 2 34]42
[bn 2 36] w
12 s,[M 2 44]42
[cn 2 18] w
12 w12 w12 w22 w,[M 2 52]42
[cn 2 17] w
12 w12 w22 w22 w12,w32
[cn 2 34] w
12
[cn 2 35] w
12
[x(152n) 2 36] w
12
[y(152n) 2 17] w
12 w12 w12
[y(152n) 2 18] w
12
[y(152n) 2 16] w
12
[y(152n) 2 45] w
22
[y(152n) 2 32] w
12
[y(152n) 2 36] w
22 w12 w12
[y(152n) 2 42 2 18] w
12
[z(152n) 2 33] w
12
apE symbolizes pyroglutamic acid.
bPotential deprotonation sites in boldface.
cIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
dNeutral loss from parent ion.
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the CID of hirudin, the fibrinopeptide B spectra are
dominated by c and y cleavages and internal ions. Some
b, a, and z ions also form. There is a distinct difference
in dissociation patterns for the two parent ions. The
spectrum of [M 2 4H]42 is dominated by neutral loss
(e.g., [M 2 44]42, [M 2 34]42, and [M 2 44 2 18]42),
whereas the spectrum of [M 2 3H]32 does not show
this neutral loss directly from the parent ion. In addi-
tion, other differences are found. For example, [M 2
4H]42 produces [z4 2 33]
12 (H2O 1 CH3 5 33 Da), but
no z ion is produced by [M 2 3H]32. Niwa and co-
workers [42] also observed differences in dissociation
patterns for [M 1 2H]22 and [M 1 3H]31 for substance
P and attributed this to the difference in coulomb
energy of the two charge states.
Loss of neutrals from fragment ions is common for
this peptide. For instance, [cn 2 18], n 5 2, 3, 5, and 9,
are produced from [M 2 4H]42. Furthermore, sequen-
tial loss of NH3 is observed; for example, [M 2 34]
42
and [M 2 34]32. Loss of NH3 is reported to originate
from asparagine (N) [16, 43]; it may also originate from
glutamine (Q). This is consistent with the present re-
sults, where internal ions such as [(b3y8)3 2 34]
12 and
[(b4y8)2 2 17]
12 lose NH3. The loss of CH3 (15 Da) is
indicative of alanine (A) for singly charged negative
peptide ions [13, 23, 25]. Our results also show that only
fragments containing alanine give neutral loss of 15 Da;
for example, [z4 2 33]
12 (H2O 1 CH3 5 33 Da) and
[y3 2 32]
12 (NH3 1 CH3 5 32 Da). Both parent ions,
[M 2 3H]32 and [M 2 4H]42, produce fragments with
loss of CO2 (44 Da). As discussed in the previous
section, this neutral loss is very common to negative ion
dissociation and is thought to originate from the C-
terminal residue [13–16, 24, 25, 44]. Loss of 30 Da, which
is indicative of CH2O elimination from serine [13],
occurs for at least one internal ion fragment [(b6y1)7 2
Figure 5. SORI-CID mass spectra of (a) [M 2 4H]42 and (b)
[M 2 5H]52 for insulin chain A oxidized.
Table 8. Table of internal ion fragments and neutral loss for [M 2 4H]42 of fibrinopeptide B
Fib. B
n 5
pEa
1
G
2
V
3
N
4
Db
5
N
6
E
7
E
8
G
9
F
10
F
11
S
12
A
13
R
14
Internal ionc
w12, (b3y9)2 2 17 s
21, (b7y6)1 w
12, (b10y3)1
w12, (b3y9)2 2 35
w12, (b8y4)22
w12, (b5y7)2 2 18 w
12, (b8y4)2
w12, (b6y5)3 2 18
w12, (b5y7)2 2 17 w
12, (b9y2)3 2 17
w22, (b3y6)5
w32, (b2y4)8
w12, (b3y9)2 2 34
w32, (b3y3)8
w22, (b5y3)6
w22, (b3y2)9 2 18
apE symbolizes pyroglutamic acid.
bPotential deprotonation sites in boldface.
cThe internal ion is composed of the underlined residues.
dIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
112 EWING AND CASSADY J Am Soc Mass Spectrom 2000, 12, 105–116
30]12. Loss of 42 Da, HN¢C¢NH, is indicative of argi-
nine [23, 25] and is only observed for fragments con-
taining this residue; for instance, [y1 2 42 2 18]
12.
Using on-resonance CID data, breakdown curves
were made of product formation versus collision en-
ergy for fibrinopeptide B ions. They exhibit the same
trends that were found for hirudin (54–65). That is,
neutral loss from the parent ion is the lowest energy
process; for example, the fragment [M 2 4H 2 NH3]
42
reaches a maximum at ;50 eV but then quickly disap-
pears to less than 5% relative abundance. As the colli-
sion energy increases, first standard peptide cleavages
occur, followed by internal ion formation, and then
neutral loss from these fragments.
The [M 2 4H]42 and [M 2 3H]32 CID data provide
complementary information. Neither parent ion cleav-
ages at every residue, but between the two spectra,
cleavage at every residue occurs (albeit often with
neutral loss). From the y and c ions in Tables 5 and 7,
there is cleavage at every residue; for instance, cn
d2, n 5
1– 4 and then a combination of [yn 2 17]
12 and [yn 2
18]d2 ions. Furthermore, the prevalent internal ions, for
example (b6y2)6
12 and [(b6y1)7 2 30)]
12, can provide
sequence information. In this manner, complete pri-
mary structural elucidation is obtained from this single,
underivatized peptide by employing low-energy disso-
ciation techniques.
Insulin Chain A (Oxidized) [M 2 4H]42 and
[M 2 5H]52
Insulin chain A (oxidized) is a 21 residue peptide that is
part of the insulin hormone, which is pivotal in glucose
metabolism [38]. The peptide has six acidic residues,
including four highly acidic sulfated cystine residues
(i.e., cysteic acid residues) and the C-terminus as poten-
tial deprotonation sites. A maximum charge state of
Table 9. Table of standard cleavages and neutral loss for [M 2 4H]42 of insulin chain A oxidized
Insulin A
n 5
G
1
I
2
V
3
Ea
4
Q
5
Cyxb
6
Cyx
7
A
8
S
9
V
10
Cyx
11
S
12
L
13
Y
14
Q
15
L
16
E
17
N
18
Y
19
Cyx
20
N
21
an w
32
cn w
22c w32 w32 w42
z(222n) w32
[an 2 18] w
32
[bn 2 18] w
32
[cn 2 17] w
32
[cn 2 18] w
32
[cn 2 35] w
32
[x(222n) 2 18] w
42 w2
[x(222n) 2 54] w
32
[y(222n) 2 18] w
42
[y(222n) 2 44] w
32 m,d [M 2 18]42
[y(222n) 2 61] w
32 w, [M 2 61]42
[z(222n) 2 18] w
32 w, [M 2 Tyr]42
aPotential deprotonation sites are in boldface.
bCyx symbolizes cysteic acid.
cIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
dNeutral loss from parent ion.
Table 10. Table of internal ion fragments and neutral loss for [M 2 4H]42 of insulin chain A oxidized
Insulin A
n 5
G
1
I
2
V
3
Ea
4
Q
5
Cyxb
6
Cyx
7
A
8
S
9
V
10
Cyx
11
S
12
L
13
Y
14
Q
15
L
16
E
17
N
18
Y
19
Cyx
20
N
21
Internal ionc
w42, (b1y3)17
w22, (b1y5)15 2 34
w42, (b1y1)19
w32, (b1y4)17
w32, (b1y2)18 2 18
w32, (b1y2)18
w32, (b1y1)19
aPotential deprotonation sites in boldface.
bCyx symbolizes cysteic acid.
cIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
dThe internal ion is composed of the underlined residues.
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[M 2 7H]72 has been previously reported [4, 45]. Un-
der our ESI/FT-ICR conditions, the major parent ions
were [M 2 nH]n2, n 5 2– 6.
The most intense ions, [M 2 4H]42 and [M 2 5H]52,
were chosen for CID studies. Figure 5 gives their
SORI-CID spectra. Tables 9 and 11 list the standard
peptide cleavages, while Tables 10 and 12 list the
internal fragment ions. As was the case with the other
two peptide systems, the dissociation products are
primarily c, y, and internal ions, with significant neutral
loss.
Relative to the other two peptides studied, insulin A
shows less neutral loss from its parent ions and less
abundant loss of multiple neutrals in its fragment ions.
The reason for this difference is not clear. It is possible
that H2O elimination involves adjacent aspartic acids
and glutamic acid residues, which do not occur in this
peptide. Furthermore, insulin A is significantly larger
than the other two peptides; there may be conforma-
tional factors that prohibit the rearrangements that are
necessary for neutral eliminations. Also, insulin A [M 2
5H]52 did not give any neutral elimination directly
from the parent ion under SORI-CID conditions, al-
though [M 2 4H]42 eliminates H2O and a tyrosine side
chain (106 Da). (Loss of 106 Da from tyrosine has
previously been reported in the negative ion mode [15,
23].) In contrast, for the two other peptides, the higher
charge state parent ions gave more neutral loss than the
lower charge state ions.
For [M 2 5H]52, a number of fragments retain the
charge of the parent ion; for instance, c20
52 in Table 11
and c20
42 in Table 9. These fragments suggest that the
acidic residues, E4, Cyx6, Cyx7, Cyx11, E17, and Cyx20 are
likely sites of deprotonation. In fact, for c20
52, it is
probable that either Cyx6 or Cyx7 is deprotonated,
along with four other deprotonation sites to produce
the c20
52 ion. In addition, internal ion fragments are
formed with only the N- and C-terminus residues
cleaved. These fragments were also multiply charged,
for example, (b1y9)19
42 and (b1y1)19
32 (see Table 10). They
further support the concept that the acidic residues are
sites of deprotonation. For internal ions, at least one of
the backbone cleavages occurs adjacent to an acidic
group (Cyx20 and N21). This is consistent with acidic
residues promoting fragmentation both C- and N-ter-
minal to the deprotonation site (as was observed for the
Table 11. Table of standard cleavages and neutral loss for [M 2 5H]52 of insulin chain A oxidized
Insulin A
n 5
G
1
I
2
V
3
Ea
4
Q
5
Cyxb
6
Cyx
7
A
8
S
9
V
10
Cyx
11
S
12
L
13
Y
14
Q
15
L
16
E
17
N
18
Y
19
Cyx
20
N
21
an w
12c w32
cn w
12 w32 w32 w52, w42
y(222n)
[bn2 2 34] w
12 w12 w12
[cn 2 18] w
12 s32 w32 w32
[x(222n) 2 88] w
52
[y(222n) 2 18] m
12
[y(222n) 2 44] w
52 w32
aPotential deprotonation sites are in boldface.
bCyx symbolizes cysteic acid.
cIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
Table 12. Table of internal ion fragments and neutral loss for [M 2 5H]52 of insulin chain A oxidized
Insulin A
n 5
G
1
I
2
V
3
Ea
4
Q
5
Cyxb
6
Cyx
7
A
8
S
9
V
10
Cyx
11
S
12
L
13
Y
14
Q
15
L
16
E
17
N
18
Y
19
Cyx
20
N
21
Internal ionc
m12, (b4y12)5 2 32
w12,d(b14y3)4
w12,(b11y6)4
w12, (b1y16)4 2 17 m
12, (b9y7)5 2 57
w12, (b1y16)4 w
12, (b14y2)5 2 36
m32, (b3y3)15
w22, (b3y3)15 2 57
w12, (b2y13)6 2 34
w32, (b4y5)12 2 44
aPotential deprotonation are sites in boldface.
bCyx symbolizes cysteic acid.
cThe internal ion is composed of the underlined residues.
dIntensities are w is weak (,30% of the base peak), m is medium (30%–60%), and s is strong (.60%). The superscript gives the charge on the
fragment ion.
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other two peptides). In a previous report on the
dissociation of [M 2 4H]42 for insulin chain A oxi-
dized, Loo et al. [4] found prevalent b and y ions and
significant loss of SO3 (80 Da). In the present study,
no such neutral loss is seen for either multiply
charged parent ion. In addition, Loo et al. [4] did not
observe the significant c ions or internal ions that are
found in the present study. It is probable that many of
these differences lie in data interpretation. In the
triple quadrupole study [4], peaks were relatively
broad, with low resolution; our FT-ICR data gave
sharper peaks at much higher resolutions, which
facilitated assignments of ion mass and formula. In
particular, the higher resolution of the FT-ICR allowed
us to unambiguously determine the charge states of the
fragment ions by using the mass-to-charge spacings of
the carbon-13 isotopic peaks [49].
Sequence information is more difficult to obtain
from the oxidized insulin A CID spectra than it is
from the spectra of the two smaller peptides. For
oxidized insulin A, primary structural information
must be garnered from the internal fragments be-
cause no series of ions give cleavage at every residue.
This relative lack of fragmentation suggests that the
highly acidic cysteic acid residues are localizing the
charge and limiting fragmentation, in analogy to
what has been reported by Summerfield and Gaskell
[29] for three small peptides containing cysteic acid.
Also, in the positive mode, highly basic arginine
residues can sequester the charge and limit dissocia-
tion [50 –52].
Conclusions
The dissociation patterns for multiply charged negative
ions of three commercially available peptides were
investigated using low-energy CID in a FT-ICR mass
spectrometer. These compounds are highly acidic and
did not produce sufficient positive ions for study by
CID. The negative mode spectra indicated that the
likely deprotonation sites are acidic residues (aspartic,
glutamic, and cysteic acids) and the C-terminus. The
spectra are rife with c, y, and internal ions, although
some a, b, x, and z ions form. Many fragment ions were
produced from cleavage adjacent to acidic residues,
both N- and C-terminal to the acidic site. In addition,
neutral loss (e.g., NH3, CH3, H2O, and CO2) occurs from
the parent ions and the fragment ions. Neutral elimina-
tions were often indicative of specific amino acid resi-
dues. The fragmentation patterns from several charge
states of the parent ions, when combined, provide
significant primary sequence information. The present
results suggest that negative peptide ion dissociation of
highly acidic peptides provides useful structural infor-
mation in cases where positive ion dissociation does not
provide sufficient ion signal.
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